ipl-logo

Business Ethics Case Study: Valeant Pharmaceutical

968 Words4 Pages

Valeant pharmaceutical’s main problem is they are acquiring smaller corporations rapidly for current growth, but they are not planning for future impacts to the company. Valeant has also shut down many research and development departments because of acquisitions. This is a problem because it would be hard to conduct research in the future if they want to go back to making more of their own products. A lesser but still prevalent problem is Valeant’s need to keep up with growing technology so they can have the latest and best product in the market. The main problem is Valeant is executing too many quick acquisitions and not planning for future difficulties. One alternative that would help the problem would be to restore some of the R&D programs …show more content…

To start, an action that Valeant will be taking is reducing how many acquisitions that they are currently performing. A positive consequence of reducing the rapid acquisitions is Valeant being able to focus more on a few companies rather than have too many companies and miss opportunities or potential problems. Another positive is Valeant would have more resources to put forth other possible projects they want to achieve. Since pharmaceuticals is always growing they will need to put resources in new technology. A negative consequence is slowing down what Valeant is good at. This strategy could backfire and Valeant could be left with less companies and opportunities for revenue. The ever-growing market also can be a negative effect of this action because Valeant could miss out on a company with a new ground breaking drug. A positive consequence of funding more R&D and creating some generic drugs would be Valeant being able to compete with companies they couldn’t before. With a generic drug Valeant could sell it at a lower price. Making a product that is not innovative would be a negative consequence. Valeant’s revenues might not be as significant if they are trying to make a generic version of a drug already out on the market instead of creating a new innovative one. Another negative consequence is that refunding the R&D department could cost Valeant more in the long run than acquiring a small company for its new

Show More
Related

  • Meat Labeling Industry In Upton Sinclair's The Jungle

    1028 Words  | 5 Pages

    Many believe that the FDA has financial reasons for allowing a drug to be on the market. In 2006, a study found that” in 22% of advisory board meetings, more than half the members had direct financial in the companies whose medial products they evaluated or their rivals”. The FDA’s advisory boards should not be able to vote on companies that they have financial ties to. The FDA says they do the best they can to create an unbiased board, but it is difficult to find “top medical experts with no ties” to pharmaceutical companies. Since a number of people have complained about this, Congress decided to make the FDA cut twenty-five percent of the advisory board that has financial ties with the pharmaceutical company being evaluated over the next five years.

    Read More

  • Swot Analysis Of Stryker Corporation

    965 Words  | 4 Pages

    • The new CER revisions have put restrictions on employee’s creative and innovative abilities, which could hinder productivity. • Although the growth of the company is a strength, it can also be a weakness by the fact that as a company becomes larger and larger, sustainability can become harder to achieve. Opportunities • The acquisitions in themselves are massive opportunities for Stryker for creating new customers and products. • Expansion into other regions of the world could significantly increase their growth.

    Read More

  • Case Study Montreux Chocolates

    901 Words  | 4 Pages

    Montreaux Chocolates USA Case Key Questions Discuss the key challenges and marketing issues Andrea Torres must address at this time. Why do you feel these issues and challenges are key to the success of the new product line? 
 The first and most important issue is the name for the new Chocolate. Apollo has a share of 15.4% in the US market in the field of the confectionery product, making it the second highest after the Fischer on the market in year 2011. Such a large share of the market will mean a strengthening of relations of the Apollo with its confectionery products.

    Read More

  • Johnson & Johnson Value Chain Analysis Summary

    942 Words  | 4 Pages

    Research and development is a very important part of their value chain. It is linked throughout almost every aspect of their priority topics including product quality, reliability, and safety, access and affordability, and all the way to their product end of life. Research and development at Johnson & Johnson is used to create new products and figure out ways to improve their old products. Since there are many illnesses that do not have a cure, Johnson & Johnson invests in

    Read More

  • Eastman Kodak Essay

    1915 Words  | 8 Pages

    Often the work conducted in Kodak’s research labs related to digital technology was left unappreciated by other by the rest of the company who still believed in silver halide film as the industry standard. Kodak also faltered in its ability to put its acquisitions to use. In addition to some questionable acquisitions, Kodak’s shear inability to convert the acquired technical expertise to successful knew products proved many of its acquisitions to be a waste of time and resources. As an example, Sterling Drug was acquired in 1988 by Kodak for $5.1 billion. The company was purchased solely because the Kodak managerial team felt that the pharmaceutical industry was at its core a chemical business like itself.

    Read More

  • Northrop Grumman's Business Ethics: Case Study

    1528 Words  | 7 Pages

    Introduction In this extended essay, I will try to answer the research question “To what extent is Corporate Social Responsibility part of Arm Makers Companies? An assessment and evaluation of Raytheon’s and Northrop Grumman’s Business ethics”. Weapon companies face the issue of being socially responsible as it is a global matter. I will be mainly focusing on two companies; Raytheon and Northrop Grumman.

    Read More

  • Blackberry Case Study

    1147 Words  | 5 Pages

    INTRODUCTION It was claimed that “Innovation knows no boundaries or borders” at Blackberry Limited, formerly known as Research In Motion (RIM). The company was founded in 1984 in Waterloo, Ontario, by a 23 years old Michael Lazaridis and Douglas Fregin. Douglas has been described as right hand and childhood friend of Mike Lazaridis. The two met in grade school and stayed friends right through high-school graduation. Lazaridis has been studying electrical engineering and had dropped out of the University of waterloo.

    Read More

  • Porter's Five Forces In The Pharmacy Industry

    1156 Words  | 5 Pages

    The number of acquisitions is not so high and it depends more upon the organic expansion. • These pharmacies face informative and predictable risk from the variability of “generic conversion” • Inability of the company to keep stride with the growing private labeled brands popularity. • The in-store implementation of the store formats and services is not consistent at every

    Read More

  • Business Ethics Case Study Patagonia Essay

    549 Words  | 3 Pages

    Patagonia is a very popular clothing company that provides high quality wear designed for people that enjoy being outdoors. The provide good quality warm clothing such as jackets and flees for reasonable prices. Not only do they provide a great product, but they also make it their aim to make a positive impact by contributing to the industry and by also creating high standards and values which is something that popular brands should always do. Profitability for a company is linked to their ethical standards because it builds a reputation for the brand. It has been found that many investors determine if a company should be invested in by also looking at their social impact.

    Read More

  • Business Ethics Case Study: Monsanto's CEO

    769 Words  | 4 Pages

    1. If you were Monsanto’s CEO, how would you best balance the conflicting needs of the variety of stakeholder groups that Monsanto must successfully engage? Monsanto has improved in terms of its corporate responsibility; however it does not maintain the most ethical culture possible. Monsanto is in a difficult position, as it produces products that many people do not understand or trust. The corporation also does much business in very poor countries where it is very easy for critics to accuse Monsanto of taking advantage of people who do not know any better.

    Read More

  • Porter's Five Forces Analysis Pharmaceutical Industry

    720 Words  | 3 Pages

    Many new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the

    Read More

  • Business Ethics Case Study: The Johnson And Johnson Case

    1262 Words  | 6 Pages

    Introduction The key ethical issues that were presented in this case study were quality control, lack of customer care, responsiveness, and harming the customer. The Johnson and Johnson case may have been seen as a turning point due to many things the company did right. However, there were many ethical issues in this case which will be explored more throughout this paper.

    Read More

  • Case Analysis: Case Study: Kraft Heinz Company

    1823 Words  | 8 Pages

    • Opportunities: Global expansion, Growing product portfolio, Mergers & Acquisitions • Threats: Decreasing demand, intense competition, increasing labor wages • Strengths: Strong brand portfolio, good cash flow, global footprint • Weaknesses: Long term debt Alternatives • Increase market share in developing economies, if KHC increases their market share it will put them at a competitive advantage

    Read More

  • Rorer Converts-Poulenc Case Study

    2104 Words  | 9 Pages

    INTRODUCTION The latter decade of the 20th century brought a number of major innovations to the pharmaceutical industry, most notably a remarkable wave of successful joint ventures and mergers between big and medium players in the market. In this case study we analyzed the Rorer and Rhône-Poulenc (RP) merger in July 31, 1990 that created a major multinational company: the Rhône-Poulenc Rorer, Inc. (RPR), where the RP became the majority shareholder, owning 68 percent of the RPR’s shares. Prior to the merger, Rorer lacked the resources to access the European market, and the firm presented relatively low cash balance and rising debt which, according to financial analysts, appeared to be handicapping its strategy of growth by acquisitions.

    Read More

  • The Importance Of Business Ethics In International Business

    1039 Words  | 5 Pages

    Basically, ethics are at their essence which is it is the moral judgments about what is right and what is wrong. Business ethics is focusing on examine the policies and conduct within the context of commercial enterprise in an organizational as well as in an individual level. In business, the ethics in business is an applied ethics where professionals and researchers use principles and theories to solve any ethical problems that exist in business. At the quarter of the 20th century, as technologies like internet have made world business or international business all more viable, the business ethics domestically have grown in importance along with the power and significance of major businesses. So that, international business ethics take center stage as a major concern of the modern era.

    Read More

More about Business Ethics Case Study: Valeant Pharmaceutical

Open Document